Watchlist Price Alert

Xilio Therapeutics Inc. (XLO)

NASDAQ: XLO · Real-Time Price · USD

0.69

0.01 (1.55%)

At close: Jun 27, 2025, 3:59 PM

0.69

-0.28%

After-hours: Jun 27, 2025, 05:33 PM EDT

1.55% (1D)

Bid	0.66
Market Cap	35.72M
Revenue (ttm)	9.27M
Net Income (ttm)	-41.04M
EPS (ttm)	-0.65
PE Ratio (ttm)	-1.06
Forward PE	-0.85
Analyst	Buy

Ask	0.69
Volume	253,996
Avg. Volume (20D)	1,281,330
Open	0.68
Previous Close	0.68
Day's Range	0.66 - 0.69
52-Week Range	0.62 - 1.70
Beta	0.02

About XLO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol XLO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for XLO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Xilio Therapeutics Inc. is scheduled to release its earnings on Aug 7, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 weeks ago

-34.57%

Xilio Therapeutics shares are trading lower after ... Unlock content with Pro Subscription

3 months ago

-6.2%

Xilio Therapeutics shares are trading lower. The company reported Q4 financial results.

News

3 months ago · zacks.com

Xilio Therapeutics, Inc. (XLO) Reports Q4 Loss, Lags Revenue Estimates

Xilio Therapeutics, Inc. (XLO) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.64 per share a year ago.